Recently Viewed

Clear All
News Announcement

Aurobindo Pharma: Unit I Of Eugia Pharma Specialities Ltd. Received A Warning Letter From US FDA

14-Aug-2026 Follow Value Research Online on Google download pdfDownload PDF Aurobindo Pharma

Intimation of receipt of warning letter from US FDA by Unit 1 of Eugia Pharma Specialities Limited a wholly owned subsidiary of the Company.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan